Factor is a meal delivery service that provides fully-cooked, single-serving meals that are ready to eat after two minutes in the microwave. The service is ideal for single adults, couples, and those ...

A group of researchers at the Medical University of South Carolina (MUSC) has recently developed a new stem cell therapy with a remarkable ability to reverse new-onset type 1 diabetes (T1D) in a mouse ...

Understanding the patterns of acquired resistance to epidermal growth factor receptor (EGFR) TKI treatment has led to more effective combination therapy and continues to drive development of novel ...

Researchers at McGill University and the Research Institute of the McGill University Health Center (RI-MUHC) have developed a novel device to transplant insulin-producing cells that integrates ...

Researchers at Karolinska Institutet and KTH Royal Institute of Technology have developed an improved method for creating insulin-producing cells from human stem cells. In a newly published study, the ...

I’m already loving this device, and I haven’t even touched one. Arduino announced it has collaborated with M5Stack to develop the new compact and powerful Nesso N1 IoT development kit. This system ...

Research on preventing type 1 diabetes often focuses on limiting the autoimmune response that destroys the body’s ability to produce its own insulin. A new technology developed by scientists at the ...

Norton Healthcare is opening a new islet cell lab to treat chronic pancreatitis and research a cure for Type 1 diabetes. The first phase will treat pancreatitis by transplanting a patient's own islet ...

With $55 billion earmarked to bolster its U.S. operations, Johnson & Johnson is the latest drugmaker to zero in on expansion plans that are aimed, at least in part, at abating the Trump administration ...

The story of power generation in 2025 was shaped in no small part by urgency. Load growth forecasts accelerated again, driven by artificial intelligence, data centers and industrial expansion. At the ...

Death, taxes, and stressing about what you're going to eat for lunch tomorrow—three of the universally dreaded (but inevitable) certainties in life, right? Well, not exactly. Whether you're a meal ...

CD7 is an attractive target for chimeric antigen receptor (CAR) T-cell therapy in relapsed or refractory T-cell acute lymphoblastic leukemia (ALL). Supportive results of first-in-human studies of base ...